Financials
Income statement
Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|
Total reported revenue | 41.3B | 41.8B | 37.8B | 42.5B |
Cost of revenue | 33.0B | 33.2B | 30.7B | 34.8B |
Gross profit | 8.3B | 8.6B | 7.1B | 7.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.3B | 1.5B | 1.3B | 1.5B |
Other operating expenses | 1.3B | 1.5B | 1.5B | 1.5B |
Operating income | 4.5B | 4.9B | 3.7B | 4.1B |
Non operating interest income | ||||
Income | 3.3B | 3.3B | 3.0B | 2.1B |
Expense | 23M | 23M | 23M | 22M |
Other income expense | — | — | — | — |
Pretax income | 25.7B | 21.7B | 24.8B | 24.4B |
Tax provision | 6.6B | 5.8B | 6.3B | 5.6B |
Net income | 19.0B | 15.8B | 18.5B | 18.8B |
Basic EPS | — | — | — | 287.5 |
Diluted EPS | — | — | — | 287.5 |
Basic average shares | — | — | — | 63.7M |
Diluted average shares | — | — | — | 63.7M |
EBITDA | 27.5B | 24.5B | 26.9B | 27.0B |
Net income from continuing op. | 25.7B | 21.7B | 24.8B | 24.4B |
Minority interests | -850M | -321M | -488M | -446M |
Preferred stock dividends | 0 | 0 | 0 | 0 |